We present our preliminary clinical experience with the initial and repetitive administration of the novel inotropic agent levosimendan in a cohort of 20 patients with end-stage heart failure who were acutely decompensated or whose symptoms were refractory to the usual pharmacological treatments thus necessitating hospitalization. Repetitive levosimendan infusions were administered to 9 patients (minimum 2, maximum 8 pulses). The effects of this therapy on the symptomatic status, vital signs, hemodynamic performance and clinical outcomes are discussed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
preliminary clinical
8
clinical experience
8
repetitive administration
8
patients end-stage
8
end-stage heart
8
heart failure
8
experience repetitive
4
administration levosimendan
4
levosimendan patients
4
failure preliminary
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!